Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

E163 - Dementia and Geriatric Mental Health with Dr. Danielle Goldfarb

E163 - Dementia and Geriatric Mental Health with Dr. Danielle Goldfarb

FromNEI Podcast


E163 - Dementia and Geriatric Mental Health with Dr. Danielle Goldfarb

FromNEI Podcast

ratings:
Length:
20 minutes
Released:
Nov 2, 2022
Format:
Podcast episode

Description

What are the early diagnostic stages of Alzheimer’s disease? What sort of brain changes can occur up to 20 years prior to symptoms of Alzheimer’s disease? In this episode, Dr. Danielle Goldfarb addresses these questions and much more! She shares the most current research on dementia and geriatrics relevant to clinical practice. She also shares resources for early diagnosis of dementia and treating mental health in geriatrics. Dr. Danielle Goldfarb is an Assistant Professor of Neurology and Psychiatry at the University of Arizona and a dual board-certified neurologist and psychiatrist at the Banner Sun Health Research Institute and Cleo Roberts Memory Center in Sun City, AZ.  Dr. Goldfarb cares for patients and families with Alzheimer’s disease and related dementias (ADRD). She leads several Alzheimer’s clinical trials and is involved in research efforts to explore the neuropathologic substrates of early neuropsychiatric symptoms in ADRD, to improve the safety and efficiency of  the collection of cerebrospinal fluid biomarkers in older adults, and to expand access to ADRD care and research by underserved communities.
Released:
Nov 2, 2022
Format:
Podcast episode

Titles in the series (100)

The Neuroscience Education Institute (NEI) is committed to help raise the standard of mental health by providing imaginative medical education that focuses on the highest level of learning. Each episode offers an opportunity to learn about current issues in psychiatry from key opinion leaders in the medical field. NEI's Podcast would be of value to anyone with an interest in neuropsychiatric diseases and psychopharmacology.